Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This research study is evaluating a drug called avastin in combination with standard
radiation as a possible treatment for treatment for recurrent pelvic-confined gynecological
cancer (i.e. endometrial, cervical, vulvar, ovarian or vaginal cancers).
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Genentech, Inc. Lowell General Hospital Massachusetts General Hospital Saint Anne's Hospital